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doi:10.1016/j.jmii.2010.08.008Background: Staphylococcus aureus is the major nosocomial pathogen and rapid detection of
colonized patients with subsequent precaution is needed to prevent transmission. A new assay,
the BD GeneOhmTM SaphSR assay (BD GeneOhmTM, San Diego, CA, USA), is a multiplex real-time
polymerase chain reaction (PCR) for rapid detection of both methicillin-sensitive S aureus
(MSSA) as well as methicillin-resistant S aureus (MRSA).
Methods: Anterior nasal swab specimens of 273 pediatric and adult patients hospitalized in
intensive care units at Chang Gung Memorial Hospital were collected for this assay in parallel
with conventional cultures as standard.
Results: Overall, 71 (26.0%) patients were colonized with S aureus by conventional culture and
MRSA accounted for 67.6% of all isolates. For the detection of MRSA, 79 patients (28.9%) were
positive by PCR and 48 (17.6%) were positive by conventional cultures. The sensitivity, speci-
ficity, and positive and negative predictive values were 95.9%, 85.3%, 58.5%, 99.0%, respec-
tively. For the detection of MSSA, 48 patients (17.6%) were positive by PCR and 23 (8.4%)
were positive by conventional culture. The sensitivity, specificity, and positive and negative
predictive values were 91.3%, 89.2%, 43.8%, and 99.1%, respectively.
Conclusion: As a screening method, the BD GeneOhmTM StaphSR assay could rapidly detect and
differentiate between MRSA and MSSA colonization. A negative result of the assay could almost
exclude S aureus colonization.
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Staphylococcus aureus, regardless of methicillin-resistance
(MRSA) or methicillin-susceptibility (MSSA), is among the
major nosocomial pathogens worldwide, including in
Taiwan.1 They can cause wide spectrum of infections from
systemic infections, such as sepsis and catheter-related
infections, to local infections, such as skin and soft tissue
infections or surgical site infections. Patients colonized
with S aureus, especially MRSA, may spread to other
patients and can serve as reservoirs for subsequent infec-
tions.2,3 Compared with MSSA, infections caused by MRSA
are associated with higher mortality, hospital stay, and
costs.4,5
In recent years, hospital infection controls have put
emphasis on rapid detection of MRSA-colonized patients to
improve patient care. Some reports had showed that active
surveillance of MRSA colonization might decrease relevant
mortality and morbidity,6,7 and these measures had became
a part of new guidelines by Center for Disease Control and
Prevention of the United States.8 In many European coun-
tries, recommendations are made for MRSA screening on
cultures from nares, skin, or mucosa.9 In the Netherlands,
the “search-and-destroy” methods even had decreased the
MRSA prevalence of all staphylococcal infections to less
than 1%.10
To detect MRSA/MSSA colonization, conventional culture
requires 48e96 hours. Some selective agars, such as CHRO-
Magar MRSA medium (BD Diagnostics, Sparks, MD, USA),
MRSA ID (bioMerieux, Portland, USA), MRSASelect (Bio-Rad
Laboratories, CA, USA) could shorten turnaround time within
18e24 hours.11,12 Because early detection of MRSA/MSSA
colonization would facilitate identification of carriers and
therefore allow early intervention to prevent spread or
infections, several nucleic acid amplification-based assays,
such as BD GeneOhm MRSA real-time polymerase chain
reaction (PCR) assay (BDGeneOhm, San Diego, CA, USA),
hyplex StaphyloResist multiplex PCR-ELISA system (BAG,
Lich, Germany), GenoType MRSA Direct (Hain Lifescience,
Nehren, Germany), and IDI-MRSA assay (Infecto Diagnostics,
Inc., Sainte-Foy, Quebec, Canada) have been developed and
can yield results within 2 hours.13e15 However, these assays
could only identify MRSA but could not identify MSSA.
A new assay, called BD GeneOhmTM StaphSR assay (BD
GeneOhm, San Diego, CA, USA), is a multiplex real-time
PCR method that uses primers specific for various staphy-
lococcal cassette chromosome (SCC) mec right-extremity
sequences and a probes and primers specific for the S
aureus chromosomal orfX gene to the right of the SCC mec
insertion site.14,15 This assay is the first product that offers
not only rapid detection of S aureus but also differentiation
between MRSA and MSSA. Preliminary results16e18 showed
fair value in rapidly differentiating bacteremia caused by
MRSA and MSSA from bloodstream samples. However,
additional specimen claims, including nasal or wound
samples, are under study. In this article, we evaluated the
performance of this assay in parallel with conventional
cultures as standard for detection of MRSA and MSSA from
anterior nares specimens of pediatric and adult patients
hospitalized in intensive care units (ICUs) to determine the
usefulness for rapid screening.Material and methods
This study was conducted at Chang Gang Memorial Hospital,
a 4000-bed, university-affiliated teaching hospital and was
approved by the Institutional Review Board.
Patients
A total of 273 patients, including 167 adults (80 in surgical
ICUs and 87 in medical ICUs), 15 children in pediatric ICUs,
and 91 newborns in neonatal ICUs, hospitalized in ICUs at
Chang Gung Memory Hospital were screened for MRSA/MSSA
nasal colonization. Patients who had very unstable vital
signs or those with pulmonary tuberculosis were excluded.
These patients were not known to previously be colonized
or infected with MRSA/MSSA.
Specimen collection
In each patient, nasal swab specimen was collected from
the anterior nares using two separate dry Copan Transystem
Liquid Stuart swabs (Venturi Transystem; Copan Diagnos-
tics, Corona, CA, USA). Each swab was rubbed inside the
anterior nares, first into one side and then into the other,
ensuring that each swab contained specimens of both nares
of each patient. These swabs were then transported at
room temperature and processed within 4 hours.
Conventional culture and broth enrichment
One of two swabs from each patient was inoculated into
trypticase soy agar with 5% sheep blood (TSA II 5% SB) plate
(Becton, Dickinson and Comapany, Sparks, MD, USA) for
conventional culture. Isolates of S aureus and MRSA iden-
tification by oxacillin susceptibility with the disc diffusion
methods were confirmed according to the recommenda-
tions of Clinical and Laboratory Standards Institute.
Another swab from the same patient was sent for BD
GeneOhm StaphSR assay. If the results showed positive for
MRSA or MSSA, this swab would be put into Mueller Hinton
Broth (Becton, Dickinson and Company, Sparks, MD, USA) in
CO2 incubator at 37
C overnight and then was subcultured
into TSA II 5% SB plate and identified using same methods.
BD GeneOhm StaphSR assay
The BD GeneOhm StaphSR assay uses the same primers and
probes forMRSAdetectionas theBDGeneOhmMRSA real-time
PCR assay. These primers and probes have been described in
details previously.19 The MRSA assay uses primers specific for
various SCCmec right-extremity sequences and a primer and
probes specific for the S aureus chromosomal orfX gene
located to the right of the SCCmec insertion site.
Specimen preparation
The assay was performed according to the manufacturer’s
instructions. One of two swabs from one patient was inocu-
lated into 1 mL of buffer in a tube labeled with sample
number. The sample buffer tube was subjected to a vortex at
high speed for 1 minute, and 600e700 mL of cell suspension
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The lysis tube was then subjected to a vortex for 5 minutes at
high speed, then the supernatant was removed. Fifty micro-
liters of sample bufferwas added to the lysis tubeand the tube
was again subjected to a vortex for 5 minutes at high speed,
centrifuged briefly (quick spin), and then heated at 95C for 2
minutes to inactivate possible PCR inhibitors. The sample was
placed on ice for immediate testing or refrigeratedat 2Ce8C
for 4 hours or at 20C until the assay was performed.
Assay procedure
The 25mL Master Mix was reconstituted and aliquoted into
labeled SmartCycler tubes (Cepheid, Sunny Vale, CA, USA).
Three microliters of the sample from the lysis tube was
added to the corresponding labeled SmartCycler tube.
Positive and negative PCR controls were also prepared and
included with each run. All reagents and samples were kept
at 2Ce8C. The SmartCycler tubes were centrifuged with
high speed. To detect inhibition material of the PCR, the
assay includes a non-S aureus sequence, which serves as an
internal control. The PCR results were interpreted using the
SmartCycler software with decisional algorithm to interpret
the assay result. If the samples contain both MRSA and
MSSA, the result would only show MRSA.
Results
Overall results
Overall, 71 (26.0%) patients were colonized with S aureus by
conventional culture and MRSA accounted for 67.6% of all
isolates. For MRSA detection, 79 patients (28.9%) were
positive by PCR method and 48 (17.6%) were positive by
conventional culture. BD GeneOhm StaphSR assay, compared
with conventional agar culture for MRSA detection, had
a sensitivity of 95.9%, specificity of 85.3%, positive predic-
tive value of 58.5%, and negative predictive value of 99.0%
(Table 1). For MSSA detection, 48 patients (17.6%) were
positive by PCR method and 23 (8.4%) were positive by
conventional culture. BD GeneOhm StaphSR assay, compared
with conventional agar culture for MSSA detection, had
a sensitivity of 91.3%, specificity of 89.2%, positive predic-
tive value of 43.8%, and negative predictive value of 99.1%
(Table 2). Only two (0.5%) samples produced false negative
results for MRSA detection and 2 (0.7%) for MSSA detection.
Broth culture
MRSA PCR showed 30.3% of culture as positive (10/33) and
18.5% showed (5/27) MSSA PCR positive but conventional
culture-negative samples showed growth on broth culture.
Broth culture increased positive predictive value from
58.5% to 70.9% for MRSA detection and from 43.8% to 54.2%
for MSSA detection.
Discrepant results
Three samples showed discrepant results. Sample 1 yielded
MRSA in PCR but MSSA in conventional and broth culture.Sample 2 yielded MSSA in PCR but MRSA in conventional
culture and nogrowth inbroth culture. Sample 3 yieldedMRSA
in PCR and conventional culture but MSSA in broth culture.
Discussion
To our knowledge, this is the first report for the perfor-
mance of the BD GeneOhm StaphSR assay from anterior
nares samples to detect staphylococcal colonization and
also to differentiate between MRSA and MSSA. Compared
with conventional culture (as standard), the BD GeneOhm
StaphSR assay showed a high sensitivity (>90%), a high
specificity (>85%), a high negative predictive value (>99%)
but a relative low positive predictive value (<60%) for both
MRSA and MSSA detection. These results were comparable
with those reported previously regarding BD GeneOhm
StaphSR assay for bloodstream samples, except for positive
predictive value.
In the present study, a large portion of samples showed
PCR-positive but culture-negative results. A simple reason
was that there were no viable bacteria for growth form
culture but residual DNA was successfully amplified by PCR.
This situation might occur after exposure to antibiotics or
decolonization therapy, but it was not evaluated in this
study. Secondly, the culture samples were collected from
anterior nares harboring polymicrobial colonization envi-
ronment, which was different from that of bloodstream
sample. These microorganisms and their products or cyto-
kines might affect MRSA/MSSA growth in culture. As
reported,16 CoNS (coagulase-negative staphylococci) may
obscure or inhibit MSSA growth in culture. In this study, we
only identified MRSA or MSSA colonies from culture plate
but ignored other colonies. If we analyzed all colonies
growing on culture plate, the results might be a little
different. The other possibility was non-mecA-containing
SCC elements19,20 or unamplifiable mecA gene, which were
carried by some CoNS or MSSA strains and may result in
detectable SCC elements targeted by BD GeneOhm StaphSR
assay and false PCR-positive as MRSA or MSSA. As reported
by other authors,14,21 about 5% specimens identified as
MRSA by BD GeneOhm MRSA assay were MSSA phenotype.
This phenomenon provided the view of heterogenecity of
SCCmec and needed further investigation.
Because the colonization and disease burden of MRSA/
MSSA continue to increase worldwide, a new PCR-based
assay with high specificity and positive predicative value
must be developed. By BD GeneOhm StaphSR assay, PCR-
positive results are only preliminary and require confirma-
tion of final culture reports. In addition, the new BD
GeneOhm StaphSR assay costs about $35 per patient, higher
than $25 for the old BD GeneOhm MRSA Assay and $4.59 for
CHROMagar MRSA.22 Although MSSA could also cause serious
nosocomial infection, nasal carriers of MRSA were much
more likely to develop staphylococcal bacteremia than
nasal carriers of MSSA.23 Whether it is worth to spend
additional price to simultaneously detect MRSA and MSSA
colonization in nonsterile sites is a problem of cost
effectiveness.
There were only four false-negative (PCR-negative but
culture-positive) samples, including two MRSA and two
MSSA. It was possible that because of either low levels of
Table 1 BD GeneOhm StaphSR assay diagnostic performance compared with conventional streaking method for MRSA
detection in patients in ICUs
BBLTM TSA II 5% SB plate/
BD GeneOhm StaphSR assay
Positive Negativea Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Adult ICUs (nZ 167)
Positive 28 23 100 83.5 54.9 100
Negativea 0 116
Surgical (nZ 80)
Positive 7 9 100 87.7 43.8 100
Negative 0 64
Medical (nZ 87)
Positive 21 14 100 78.8 60 100
Negative 0 52
Pediatric ICUs (nZ 106)
Positive 18 10 90 88.3 64.2 97.4
Negative 2 76
Pediatric (nZ 15)
Positive 5 3 100 70.0 62.5 100
Negative 0 7
Newborn (nZ 91)
Positive 13 7 86.6 90.8 65.0 97.2
Negative 2 69
Total (nZ 273)
Positive 46 33 95.9 85.3 58.5 99.0
Negative 2 192
a Results showing negative or growth of MSSA.
ICUZ intensive care unit; MRSAZmethicillin-resistant Staphylococcus aureus; NPVZ negative predictive value; PPVZ positive
predictive value; TSA II 5% SB plateZ trypticase soy agar with 5% sheep blood.
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MRSA/MSSA on the swabs from anterior nares were below
the detection limit of the BD GeneOhm StaphSR assay but
were enough to grow in culture. The limit of BD GeneOhm
StaphSR assay had been reported to be 15 DNA copy
numbers per reaction mixture or 10 colony forming units
per reaction mixture for both MRSA and MSSA16 or to be 103
colony forming units/specimen for MRSA.24 Besides, these
samples were collected from anterior nares where other
microorganisms, such as CoNS or Streptococcus species may
also colonize; some inhibitors may interfere with PCR.
Because BD GeneOhm StaphSR assay was designed to target
a highly conserved sequence that bridges the orfX and the
major variant SCCmec Types I to IV, a novel SCCmec-
harboring MRSA strain may also produce false-negative
results. Contamination of the culture during procedure may
produce false-positive culture report but it was least likely.
The low false-negative rate produced almost 100% negative
predictive value (99.0% in MRSA and 99.1% in MSSA), which
were compatible with other studies in literature.25e27 The
high negative predictive value suggests that in a population
with a low prevalence of MRSA, BD GeneOhm StaphSR assay
can serve as a rapid method for screening people who are
not colonized; and for people who are tested PCR-negative,
culture might be spared to save unnecessary costs and
decrease complexity of assay algorithms.
Besides conventional culture using TSA II 5% SB plate, we
added broth enrichment culture for PCR-positive samples.PCR-negative samples were not sent for broth enrichment
culture in our study. By adding broth culture, we detected
additional 10 MRSA and 5 MSSA cultures from PCR-positive
but conventional culture-negative samples and therefore
increased positive predictive value from 58.5% to 70.9% in
MRSA and 43.8% to 54.2% in MSSA. However, broth culture
required additional overnight incubation, technique, and
costs. Because of high negative predictive value of BD
GeneOhm MRSA assay, we suggested broth culture only in
PCR-positive samples to decrease false-positive rate.
Three samples showed discrepant results. As afore-
mentioned, non-mecA-containing SCC elements19,20 or
unamplifiable mecA gene may explain the two samples
showing MRSA in PCR but MSSA in culture. Another expla-
nation is the MRSA/MSSA co-colonization at anterior nares
and therefore PCR and culture detected different strains
respectively. Although study showed that MRSA and MSSA
competed for colonization space, MRSA/MSSA co-coloniza-
tion at anterior nares did occur in few patients.28,29
There are some limitations in this study. We did not
collect patients’ background data, including age, diseases,
previous MRSA/MSSA colonization status, and antibiotics
exposure. For samples of false-positive, false-negative, and
discrepant results, we neither performed double check nor
further molecular test, such as mecA PCR or PBP2’ assay to
confirm the PCR or culture results. Besides, if the swabs
contained both MRSA and MSSA, the BD GeneOhm StaphSR
Assay used in our study only showed MRSA.
Table 2 BD GeneOhm StaphSR Assay diagnostic performance compared with conventional streaking method for MSSA
detection in patients in ICUs
BBLTM TSA II 5% SB plate/
BD GeneOhm StaphSR assay
Positive Negativea Sensitivity (%) Specificity (%) PPV (%) NPV (%)
Adult ICUs (nZ 167)
Positive 9 18 100 83.5 54.9 99.3
Negativeb 1 139
Surgical (nZ 80)
Positive 7 9 100 87.7 43.8 100
Negative 0 64
Medical (nZ 87)
Positive 2 9 66.7 89.3 18.2 98.7
Negative 1 75
Pediatric ICUs (nZ 106)
Positive 12 9 92.3 90.3 57.1 98.8
Negative 1 84
Pediatric (nZ 15)
Positive 2 0 66.7 100 100 92.3
Negative 1 12
Newborn (nZ 91)
Positive 10 9 100 88.9 52.6 100
Negative 0 72
Total (nZ 273)
Positive 21 27 91.3 89.2 43.8 99.1
Negative 2 223
a Results showing negative or growth of MRSA.
b Results showing negative or growth of MRSA.
ICUZ intensive care unit; MRSAZmethicillin-resistant Staphylococcus aureus; NPVZ negative predictive value; PPVZ positive
predictive value; TSA II 5% SB plateZ trypticase soy agar with 5% sheep blood.
314 T.-H. Ho et al.In summary, as a screening method, the BD GeneOhm
StaphSR assay could rapidly detect and differentiate
between MRSA and MSSA colonization in humans. A
negative result of the assay could almost exclude S
aureus colonization, but a positive result should require
culture to confirm it. Although this assay was relatively
expensive, there may be an overall cost savings, espe-
cially for high-risk populations. Adequate prevention
strategy, such as mucipurin decolonization should be
implemented to avoid subsequent infection or spread
once detected.
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